floximox powder for oral (pom)
amoxycillin 125mg/5ml
floximox capsules (pom)
amoxycillin 500mg
floximox tablet
asiatic laboratories ltd. - moxifloxacin - tablet - 400 mg
floximox eye drops
asiatic laboratories ltd. - moxifloxacin - eye drops - 5 mg/ml
flexibac 25 tablet
beacon pharmaceuticals plc - baclofen - tablet - 25 mg
flexibac syrup
beacon pharmaceuticals plc - baclofen - syrup - 100 mg/100 ml
deltanil 10 mg/ml pour-on solution for cattle and sheep
virbac s.a. - deltamethrin - pour-on solution - 10 milligram(s)/millilitre - deltamethrin - cattle, sheep - ectoparasiticide
avelox abc pack- moxifloxacin hydrochloride tablet, film coated
stat rx usa - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin hydrochloride 400 mg - following oral administration of 400 mg moxifloxacin for 10 days in 16 elderly (8 male; 8 female) and 17 young (8 male; 9 female) healthy volunteers, there were no age-related changes in moxifloxacin pharmacokinetics. in 16 healthy male volunteers (8 young; 8 elderly) given a single 200 mg dose of oral moxifloxacin, the extent of systemic exposure (auc and cmax ) was not statistically different between young and elderly males and elimination half-life was unchanged. no dosage adjustment is necessary based on age. in large phase iii studies, the concentrations around the time of the end of the infusion in elderly patients following intravenous infusion of 400 mg were similar to those observed in young patients. the pharmacokinetics of moxifloxacin in pediatric subjects have not been studied. following oral administration of 400 mg moxifloxacin daily for 10 days to 23 healthy males (19-75 years) and 24 healthy females (19-70 years), the mean auc and cmax were 8% and 16% higher, respectively, in fem
ciproxin i.v. flexibag 400mg/200ml infusion
bayer plc - ciprofloxacin lactate - infusion - 2mg/1ml
ciproxin i.v. flexibag 200mg/100ml infusion
bayer plc - ciprofloxacin lactate - infusion - 2mg/1ml